Veropharm

Veropharm, established in 1997, is a prominent pharmaceutical manufacturing company based in Moscow, Russia. Specializing in the healthcare sector, the company offers a range of pharmaceutical products including uniplast, salipod, amigrenin, aprotex, and arteris-vero. Its operations are centered on producing high-quality medicines, contributing significantly to the pharmaceutical supply chain. The company's strategic focus on B2B operations and its established presence in the Russian market underscore its role as a key player in the domestic pharmaceutical industry.

With a substantial workforce of 1,000 - 5,000 employees, Veropharm operates with significant capacity. This scale allows for robust production and distribution capabilities across its single primary location. Meet Veropharm's team to learn more about the personnel driving its operational success and commitment to quality in pharmaceutical development and manufacturing. The company's operational footprint, while concentrated, is managed to ensure efficiency and adherence to industry standards.

Generating $343.3M in revenue, Veropharm demonstrates considerable market traction within the pharmaceutical and healthcare industries. Its product portfolio, featuring specialized medications, caters to specific therapeutic needs. The company's founding in 1997 signifies a long-standing commitment to its sector, building expertise and a reputation for reliability in pharmaceutical production. Veropharm's business model emphasizes technical proficiency in drug manufacturing and supply.